Suscripción a Biblioteca: Guest
International Journal of Medicinal Mushrooms

Publicado 12 números por año

ISSN Imprimir: 1521-9437

ISSN En Línea: 1940-4344

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) IF: 1.2 To calculate the five year Impact Factor, citations are counted in 2017 to the previous five years and divided by the source items published in the previous five years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) 5-Year IF: 1.4 The Immediacy Index is the average number of times an article is cited in the year it is published. The journal Immediacy Index indicates how quickly articles in a journal are cited. Immediacy Index: 0.3 The Eigenfactor score, developed by Jevin West and Carl Bergstrom at the University of Washington, is a rating of the total importance of a scientific journal. Journals are rated according to the number of incoming citations, with citations from highly ranked journals weighted to make a larger contribution to the eigenfactor than those from poorly ranked journals. Eigenfactor: 0.00066 The Journal Citation Indicator (JCI) is a single measurement of the field-normalized citation impact of journals in the Web of Science Core Collection across disciplines. The key words here are that the metric is normalized and cross-disciplinary. JCI: 0.34 SJR: 0.274 SNIP: 0.41 CiteScore™:: 2.8 H-Index: 37

Indexed in

Medicinal, Nutritional, and Cosmetic Values of Macrofungi Distributed in Mazandaran Province of Northern Iran (Review)

Volumen 21, Edición 11, 2019, pp. 1099-1106
DOI: 10.1615/IntJMedMushrooms.2019032743
Get accessGet access

SINOPSIS

A total of 82 species and 2 variations of medicinal and edible macrofungi (Basidiomycota and Ascomy-cota) have been collected and identified in Mazandaran Province of Northern Iran. Among these species, 58 possess medicinal and culinary properties, whereas 21 possess only medicinal properties (antiinflammatory, antimicrobial, an-timutagenic, antioxidant, antitumor, antiplatelet, hypoglycemic, hypocholesterolemic, neurotropic, hypotensive, insec-ticidal, immunomodulating, mitogenic/regenerative, spasmolytic, etc.). No medicinal effect has yet been reported for 4 species (Cantharellus infundibuliformis, Mycena inclinata, Suillus collinitus, Xerocomus porosporus) and 2 variations (Pluteus cervinus var. albus, Russula cyanoxantha var. variata) of edible species. Among the listed species, 15 (such as Auricularia auricula-judae, Hericium erinaceus, Fomes fomentarius, Flammulina velutipes, Ganoderma lucidum, Lyophyllum decastes, Pleurotus ostreatus, Tremella mesenterica) are currently used for manufacturing organic cosmetic products. The well-known mushrooms with medicinal properties (e.g., Auricularia auricula-judae, Flammulina velutipes, Hericium erinaceus, Ganoderma lucidum, G. tsugae, G. adspersum, Trametes versicolor) and excellent edibility (e.g., Boletus edulis, Cantharellus cibarius, Morchella esculenta, Pleurotus ostreatus) are widely distributed in the studied area. The biological resources of macrofungi growing in Mazandaran Province of Northern Iran possess medicinal, nutritional, and cosmetic values and could be further used for biotechnological exploitation to develop mushroom-derived pharmaceuticals, nutriceuticals, nutraceuticals, and cosmeceuticals.

REFERENCIAS
  1. Chang ST, Buswell JA. Nutriceuticals from mushrooms. In: Doelle HW, Rokem S, Berovic M, editors. Encyclopedia of life support systems (EOLSS): biotechnology. Vol. VII. Oxford: EOLSS Publishers; 2001. p. 53-73.

  2. Badalyan SM, Zambonelli A. Biotechnological exploitation of macrofungi for the production of food, pharmaceuticals and cosmeceuticals. In: Sridhar KR, Deshmukh SK, editors. Advances in macrofungi: diversity, ecology and biotechnology. Boca Raton (FL): CRC Press; 2019. p. 199-230.

  3. Chang ST, Wasser SP. The role of culinary-medicinal mushrooms on human welfare with a pyramid model for human health. Int J Med Mushrooms. 2012;14:95-134.

  4. Dai Y-C, Yang Z-L, Cui B-K, Yu C-J, Zhou L-W. Species diversity and utilization of medicinal mushrooms and fungi in China (review). Int J Med Mushrooms. 2009;11(3):287-302.

  5. Wasser SP. Medicinal mushroom science: history, current status, future trends, and unsolved problems. Int J Med Mushrooms. 2010;12(1):1-16.

  6. Wasser SP. Medicinal mushrooms in human clinical studies. Part I. Anticancer, oncoimmunological, and immunomodulatory activities: a review. Int J Med Mushrooms. 2017;19(4):279-317.

  7. Chang ST, Wasser SP. Current and future research trends in agricultural and biomedical applications of medicinal mushrooms and mushroom products (review). Int J Med Mushrooms. 2018;20(11):1034-48.

  8. Gargano ML, van Griensven LJLD, Isikhuemhen OS, Lindequist U, Venturella G, SP Wasser, Zervakis GI. Medicinal mushrooms: valuable biological resources of high exploitation potential. Plant Biol. 2017;151(3):548-65.

  9. Badalyan SM. Medicinal aspects of edible ectomycorrhizal mushrooms. In: Zambonelli A, Bonito G, editors. Edible ectomy-corrhizal mushrooms, current knowledge and future prospects. Vol 34. Berlin/Heidelberg: Springer-Verlag; 2012. p. 317-34.

  10. De Silva DD, Rapior S, Fons F, Bahkali AH, Hyde KD. Medicinal mushrooms in supportive cancer therapies: an approach to anti-cancer effects and putative mechanisms of action. Fungal Divers. 2012;55:1-35.

  11. De Silva DD, Rapior S, Sudarman E, Stadler M, Xu J, Alias SA, Hyde KD. Bioactive metabolites from macrofungi: ethno-pharmacology, biological activities and chemistry. Fungal Divers. 2013;62:1-40.

  12. Kues U, Badalyan SM. Making use of genomic information to explore the biotechnological potential of medicinal mushrooms. In: Medicinal and aromatic plants of the world. Vol. 4. Medicinal plants and fungi-recent advances in research and development. Singapore: Springer Nature; 2017. p. 397-458.

  13. Badalyan SM, Barkhudaryan A, Rapior S. Recent progress in research on the pharmacological potential of mushrooms and prospects for their clinical application. In: Agrawal D, Dhansekaran M, editors. Medicinal mushrooms: recent progress in research and development. Singapore: Springer Nature; 2019. p. 1-70.

  14. Hobbs C. Medicinal mushrooms: an exploration of tradition, healing and culture. Santa Cruz, CA: Botanica Press; 1995.

  15. Grienke U, Zoll M, Peintner U, Rollinger JM. European medicinal polypores. A modern view on traditional uses. J Ethno- pharmacol. 2014;154:564-83.

  16. Wu Y, Choi MH, Li J, Yang H, Shin HJ. Mushroom cosmetics: the present and future. Cosmetics. 2016;3:22.

  17. Taofiq O, Gonzalez-Paramas AM, Martins A, Barreiro MF, Ferreira ICFR. Mushrooms extracts and compounds in cosmetics, cosmeceuticals and nutricosmetics-a review. Ind Crops Prod. 2016;90:38-48.

  18. Wasser SP, Nevo E, Sokolov D, Reshetnikov SV, Timor-Tismenetsky M. Dietary supplements from medicinal mushrooms: diversity of types and variety of regulations. Int J Med Mushrooms. 2000;2:1-19.

  19. Hawksworth DL. Mushrooms: the extent of the unexplored potential. Int J Med Mushrooms. 2001;3:333-40.

  20. Boa ER. Wild edible fungi: a global overview of their use and importance to people. Food and Agriculture Organization of the United Nations: Rome; 2004.

  21. Saremi H, Ammarellou A, Mohammadi J. Morphological and ecological evaluation of truffles in Iran. In: Hall IR, Wang Y, Zambonelli A, Danell E, editors. Proceedings of the Second International Conference on Edible Mycorrhizal Mushrooms. 2001 Jul 3-6; Christchurch, New Zealand. CD-ROM. Christchurch: Institute for Crop and Food Research Limited; 2002.

  22. Rezaeian S, Pourianfar HR, Janpoor J. Collection and identification of Iranian wild mushrooms: towards establishment of a mushroom bio-bank. Int J Adv Res. 2016;4(1):256-60.

  23. Aghajani H, Marvie Mohadjer MR, Bari E, Ohno KM, Shirvany A, Asef MR. Assessing the biodiversity of wood decay fungi in northern forests of Iran. Proc Natl Acad Sci India B. 2018;88(4):1463-69.

  24. Raefipour MR, Salari N, Ali-Moussazadeh S. An introduction to some medicinal mushrooms of Iran. Plant Ecosyst. 2014;9(37):17-34.

  25. Keypour S, Riahi H, Moradali MF, Rafati H. Investigation of antibacterial activity of a chloroform extract of Ling Zhi or Reishi medicinal mushroom, Ganoderma lucidum (W. Curt.:Fr.) P. Karst. (Aphyllophoromycetideae), from Iran. Int J Med Mushrooms. 2008;10:345-9.

  26. Keypour S, Riahi H, Moradali MF, Rafati H, Mirzajani F. Qualitative analysis of ganoderic acids in Ganoderma lucidum from Iran and Chinaby RP-HPLC and electrospray ionisation-mass spectrometry (ESI-MS). Food Chem. 2010;119:1704-08.

  27. Moradali MF, Mostafavi H, Hejaroude GA, Tehrani AS, Abbasi M, Ghods S. Investigation of potential antibacterial properties of methanol extracts from fungus Ganoderma applanatum. Chemotherapy. 2006;52(5):241-44.

  28. Moradali MF, Mostafavi H, Ghods S, Hejaroude GA. Investigation of antimicrobial fatty acids from medicinal artist conk mushroom Ganoderma applanatum (Pers.) Pat. (Aphyllophoromycetidae) by TLC and spectroscopic detection. Int J Med Mushrooms. 2008;10(2):149-54.

  29. Sharifi A, Naseri MH, Jahedi S, Sarkary B, Rooz SS, Khosravani SM, Kalantar E. Antimicrobial potentials of crude fractions of polysaccharides of Ganoderma sp. African J Microbiol Res. 2012;6(39):6817-21.

  30. Tajalli F, Malekzadeh K, Soltanian H, Janpoor J, Rezaeian S, Pourianfar HR. Antioxidant capacity of several Iranian, wild and cultivated strains of the button mushroom. Braz J Microbiol. 2015;46(3):769-76.

  31. Raissian N, Khatamirad M, Zokaee M. The study of antioxidant activity of ethanolic extract of Laetiporus sulphureus. Proceed 18th Nat Congr Food Technol. Mashhad, Iran: Khorasan Sci Technol Park; 2008. p. 58.

  32. Hokmollahi F, Rafati H, Riahi H, Hakimi MH, Heydari H, Haghirosadat F, Azimzade M, Frotan A, Massazade SAM. Inves-tigation of the antioxidant activity and determination of total phenol content of medicinal mushroom, Phellinus torulosus fractional extracts from Iran. J Rafsanjan Univ Med Sci. 2011;10(1):57-69. (Farsi).

  33. Ebrahimzadeh MA, Safdari Y, Khalili M. Antioxidant activity of different fractions of methanolic extract of the golden chanterelle mushroom Cantharellus cibarius (higher Basidiomycetes) from Iran. Int J Med Mushrooms. 2015;17:557-65.

  34. Vazirian M, Faramarzi MA, Sadat Ebrahimi SE, Monsef Esfahani HR, Samadi N, Hosseini SA, Asghari A, Manayi A, Mousazadeh A, Asef MR, Habibi E, Amanzadeh Y. Antimicrobial effect of the Lingzhi or Reishi medicinal mushroom, Gan-oderma lucidum (higher Basidiomycetes) and its main compounds. Int J Med Mushrooms. 2014;16:77-84.

  35. Soltanian H, Rezaeian S-H, Shakeri A, Janpoor J, Pourianfar HR. Antibacterial activity of crude extracts and fractions from Iranian wild-grown and cultivated Agaricus sp. Biomed Res. 2015;27:842-45.

  36. Pourianfar HR, Rezaeian SH, Janpoor J, Ahmadzadeh H. In vitro anti-cancer potential and chemical analysis of Agaricus bisporus. Avicenna J Phytomed. 2015;5(S1):120.

  37. Rezaeian S, Saadatmand S, Sattari TN, Mirshamsi A. Antioxidant potential and other medicinal properties of edible mushrooms naturally grown in Iran. Biomed Res. 2016;27(1):240-47.

  38. Alinia-Ahandani E, Fazilati M, Alizadeh Z, Boghozian A. The introduction of some mushrooms as an effective source of medicines in Iran Northern. Biol Med. 2018;10(5):1-5.

  39. Olfati J, Peyvast G, Mami Y. Identification and chemical properties of popular wild edible mushrooms from Northern Iran. J Hortic For. 2009;1:48-51.

  40. Borhani A, Badalyan SM, Gharibyan NG, Ali-Mossazadeh S. Diversity and distribution of macrofungi associated with beech forests of Northern Iran (case study Mazandaran Province). World Appl Sci J. 2010;8(3):326-33.

  41. Badalyan SM, Borhani A. The diversity and distribution of edible and medicinal mushrooms from Mazandaran Province of Northern Iran. Proc Yerevan State Univ Chem Biol. 2019;53(1):33-41.

  42. Vazirian M, Faridfar S, Eftekhari M. "Gharikon'V'Agharikon": a valuable medicinal mushroom in Iranian traditional medicine. Iran J Med Sci. 2016;41(3):S34.

  43. Faridi P, Abolhassanzadeh Z, Zarshenas MM, Mohagheghzadeh A. Gout remedies in traditional Iranian medicine (TIM). Res Hist Med. 2012;1(4):105-46.

  44. Borhani A, Badalyan SM, Ali-Mossazadeh S. Study on distribution and introduction of some medicinal mushrooms with anticancer activities in northern forest of Iran. Abstracts of the 3rd Congr. Medicinal Plants. Tehran, Iran: Tehran University Press; 2007 Oct 22-25. p. 571.

  45. Borhani A, Badalyan SM, Gharibyan NG, Ali-Mossazadeh S, Yasari E. Flammulina velutipes (Curt.: Fr.) Singer: an edible mushroom in northern forest of Iran and its antagonistic activity against selected plant pathogenic fungi. Int J Biol. 2011;3(2):162-67.

  46. Badalyan SM, Borhani A, Gharibyan NN. Study on antifungal effect of xylotrophic mushrooms in northern forest of Iran. Abstracts of the 6th International Medicinal Mushrooms Conference. Zagreb, Croatia; 2011 Sep 25-29. p. 52-3.

  47. Badalyan SM, Gharibyan NG. Proteolytic and milk-coagulating activities of mycelia of several polypore mushrooms. In: Dyakov YT, Sergeev YV, editors. Current mycology in Russia. Proceed III Int. Mycol Forum. Moscow Russia: Nat Acad Mycol. Vol. 5. 2015 Apr 14-15. p. 275-77.

  48. Shirdelian A. Mushrooms finding way into Iranian food basket. Financial tribune. First Iranian English Economic Daily. 2017 Dec 3;20:29.

  49. Badalyan SM, Gharibyan NG. Antiphytopathogenic activity of mycelia polypore mushrooms (Agaricomycetes, Polyporales). In: Dyakov YT, Sergeev YV, editors. Current mycology in Russia. Proceed IV Congr Russian Mycologists. Moscow, Russia: Nat Acad Mycol. Vol. 7. 2017 Apr 12-14. p. 207-08.

  50. Badalyan SM, Shnyreva AV, Iotti M, Zambonelli A. Genetic resources and mycelial characteristics of several medicinal polypore mushrooms (Polyporales, Basidiomycetes). Int J Med Mushrooms. 2015;17(4):371-84.

  51. Badalyan SM, Gharibyan NG. Characteristics of mycelial structures of different fungal collections. Yerevan (Armenia):YSU Press; 2017.

CITADO POR
  1. Keypour Somayeh, Riahi Hossein, Asef Mohammad Reza, Abdollahzadeh Jafar, borhani Ali, Safaie Naser, Woodward Stephen, The true nature of Ganoderma in Iran: Taxonomy based on ITS and mtSSU rDNA, Forest Pathology, 2020. Crossref

  2. Angelini Paola, Venanzoni Roberto, Angeles Flores Giancarlo, Tirillini Bruno, Orlando Giustino, Recinella Lucia, Chiavaroli Annalisa, Brunetti Luigi, Leone Sheila, Di Simone Simonetta Cristina, Ciferri Maria Chiara, Zengin Gokhan, Ak Gunes, Menghini Luigi, Ferrante Claudio, Evaluation of Antioxidant, Antimicrobial and Tyrosinase Inhibitory Activities of Extracts from Tricholosporum goniospermum, an Edible Wild Mushroom, Antibiotics, 9, 8, 2020. Crossref

  3. Badalyan Susanna M., Rapior Sylvie, The Neurotrophic and Neuroprotective Potential of Macrofungi, in Medicinal Herbs and Fungi, 2021. Crossref

  4. Islam Tahidul, Ganesan Kumar, Xu Baojun, Insights into health-promoting effects of Jew's ear (Auricularia auricula-judae), Trends in Food Science & Technology, 114, 2021. Crossref

Portal Digitalde Biblioteca Digital eLibros Revistas Referencias y Libros de Ponencias Colecciones Precios y Políticas de Suscripcione Begell House Contáctenos Language English 中文 Русский Português German French Spain